A. Harari

Discipline

Histoire, Philosophie et Sociologie des sciences (6) Sciences de l'information et de la communication (2) Economies et finances (1)

Type de document

Articles (48) Recensions (11)

Co-auteur

Date

Source

Mot-clé

T cells (25) cancer (23) Cancer (23) Immunotherapy (23) Cancer (23) Immunotherapy (23) Patients (21) Patients (21) Cells (19) Treatment (15) Human beings (15) Control (13) Vaccines (13) procès (11) Tumors (11) Lymphocytes (11) Tumors (11) Infection (10) Blood (10) Expression (9) Antigens (9) thérapie (8) infection (8) analyse (8) Development (8) Will (8) Vaccination (8) Therapeutics (8) Flow cytometry (8) Comprehension (8)

Documents écrit par A. Harari (48) | parle de A. Harari (0)

Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes.
J. Racle et al. (13 juin 2023)
Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity.
H. Fritah et al. (21 avr. 2023)
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8(+ )T-cell epitopes.
D. Gfeller et al. (18 janv. 2023)
Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy.
B. Mastelic-Gavillet et al. (2023)
Towards next-generation TIL therapy: TILs enriched in neoepitope-specific T cells.
M. Arnaud et al.
Sensitive identification of neoantigens and cognate TCRs in human solid tumors.
M. Arnaud et al.
High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure.
I.T. Schrijver et al. (11 févr. 2022)
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
F.G. Herrera et al.
Vaccines as Priming Tools for T Cell Therapy for Epithelial Cancers.
L.E. Kandalaft et al. (19 nov. 2021)
A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma.
A. Harari et al. (18 nov. 2021)
Microfluidic Device for Droplet Pairing by Combining Droplet Railing and Floating Trap Arrays.
M. Duchamp et al. (6 sept. 2021)
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING.
M. Bruand et al. (20 juil. 2021)
Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
J.L. Tanyi et al. (4 mai 2021)
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
J.L. Tanyi et al. (15 mars 2021)
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting.
J. Schmidt et al. (16 févr. 2021)
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer.
A. Cachot et al.
The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients.
M. Arnaud et al. (2021)
Unsupervised Analysis of Flow Cytometry Data in a Clinical Setting Captures Cell Diversity and Allows Population Discovery.
P. Baumgaertner et al. (2021)
T-cell repertoire analysis and metrics of diversity and clonality.
J. Chiffelle et al.
Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes.
A. Orcurto et al.
Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines.
M. Graciotti et al. (2 juin 2020)
Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine.
C. Boudousquié et al. (14 janv. 2020)
Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal.
V. Bianchi et al. (2020)
Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure.
S. Vigano et al. (2020)
Microfluidic device performing on flow study of serial cell-cell interactions of two cell populations.
M. Duchamp et al. (9 déc. 2019)

next